Meta-analysis · people

Larazotide: eased GI symptoms in celiac patients on gluten challenge

Checked against the paper Meta-analysisPublished by PepVault

The takeaway

In pooled trials, larazotide was generally well tolerated and helped gut symptoms mainly when celiac patients were eating gluten, with no clear change in gut permeability.

Kind
Meta-analysis
Studied in
People
Number studied
626
Published
2022
Journal
Clin Res Hepatol Gastroenterol

What they tested

The team set out to pool every randomized trial of larazotide in people with celiac disease to see how well it works and how safe it is.

How the study was done

A systematic review and meta-analysis of randomized, placebo-controlled trials with 626 patients with celiac disease, 465 on larazotide and 161 on placebo (a dummy treatment). Some trials tested patients during a gluten challenge (eating 2.4-2.7 grams of gluten a day), and others tested patients on a gluten-free diet.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

The lactulose-to-mannitol ratio, a measure of gut permeability, did not change differently with larazotide than with placebo, whether or not patients were eating gluten. In patients on a gluten challenge, larazotide was linked to better symptom scores than placebo on both the total gastrointestinal symptom rating scale (GSRS) and its celiac-specific version (CD-GSRS). In patients on a gluten-free diet, neither symptom score differed from placebo. Larazotide also lowered gluten-related diarrhea during gluten challenge, and other side effects were similar between groups.

What it doesn’t show

The pooled evidence comes from a small number of trials, with even fewer in patients on a gluten-free diet. The authors say more randomized trials are needed to confirm the results.

The paper

Hoilat et al. Larazotide acetate for treatment of celiac disease: A systematic review and meta-analysis of randomized controlled trials. Clin Res Hepatol Gastroenterol. 2022.

The compound

More studies on Larazotide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo